For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Warwick

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601)

Type
D - Journal article
Title of journal
Lancet Oncology
Article number
-
Volume number
Vol.11
Issue number
No.3
First page of article
266
ISSN of journal
1470-2045
Year of publication
2010
URL
-
Number of additional authors
15
Additional information

The author made a substantial contribution to:

• the conception and design of the study;

• carrying out the study (including acquisition of study data);

• analysis and interpretation of study data.

In addition, the author helped to:

• draft the output; and

• critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
57
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-